RT @OphthTimes: . @REGENXBIO announces dosing of first patient in phase II ALTIT…
[ad_1]
RT @OphthTimes: . @REGENXBIO announces dosing of first patient in phase II ALTITUDE™ trial of RGX-314 for the diabetic retinopathy treatmen…
[ad_2]
Source by Thomas Ciulla, MD, MBA